Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response

Honda K, Takaoka A, Taniguchi T . Type I interferon α gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006; 25: 349–360.

Paun A, Pitha PM . The IRF family, revisited. Biochimie 2007; 89: 744–753.

Barnes BJ, Moore PA, Pitha PM . Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 2001; 276: 23382–23390.

Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243–249.

Paun A, Reinert JT, Jiang Z, Medin C, Balkhi MY, Fitzgerald KA et al. Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J Biol Chem 2008; 283: 14295–14308.

Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 2005; 280: 17005–17012.

Lin SC, Lo YC, Wu H . Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010; 465: 885–890.

Balkhi MY, Fitzgerald KA, Pitha PM . Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol Cell Biol 2008; 28: 7296–7308.

Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly P et al. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J Biol Chem 2005; 280: 21078–21090.

Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–555.

Sigurdsson S, Padyukov L, Kurreeman FA, Liljedahl U, Wiman AC, Alfredsson L et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 2007; 56: 2202–2210.

Kozyrev SV, Alarcon-Riquelme ME . The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 2007; 40: 591–601.

Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610–2615.

Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV . TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006; 203: 553–561.

Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB−/−Yaa and FcgammaRIIB−/− mouse models of systemic lupus erythematosus. J Immunol 2010; 184: 796–806.

Lien C, Fang CM, Huso D, Livak F, Lu R, Pitha PM . Critical role of IRF-5 in regulation of B-cell differentiation. Proc Natl Acad Sci USA 2010; 107: 4664–4668.

Barr TA, Brown S, Mastroeni P, Gray D . B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c. J Immunol 2009; 183: 1005–1012.

Coutinho A, Forni L . Intraclonal diversification in immunoglobulin isotype secretion: an analysis of switch probabilities. Embo J 1982; 1: 1251–1257.

Guay HM, Andreyeva TA, Garcea RL, Welsh RM, Szomolanyi-Tsuda E . MyD88 is required for the formation of long-term humoral immunity to virus infection. J Immunol 2007; 178: 5124–5131.

Ippagunta SK, Malireddi RK, Shaw PJ, Neale GA, Walle LV, Green DR et al. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat Immunol 2011; 12: 1010–1016.

Stavnezer J . Molecular processes that regulate class switching. Curr Top Microbiol Immunol 2000; 245: 127–168.

Snapper CM, Finkelman FD, Paul WE . Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev 1988; 102: 51–75.

Dunnick WA, Shi J, Holden V, Fontaine C, Collins JT . The role of germline promoters and I exons in cytokine-induced gene-specific class switch recombination. J Immunol 2011; 186: 350–358.

Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553–563.

Sellars M, Reina-San-Martin B, Kastner P, Chan S . Ikaros controls isotype selection during immunoglobulin class switch recombination. J Exp Med 2009; 206: 1073–1087.

Peng SL, Szabo SJ, Glimcher LH . T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci USA 2002; 99: 5545–5550.

Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006; 7: 773–782.

Thompson EC, Cobb BS, Sabbattini P, Meixlsperger S, Parelho V, Liberg D et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 2007; 26: 335–344.

Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996; 5: 537–549.

Sellars M, Reina-San-Martin B, Kastner P, Chan S . Ikaros controls isotype selection during immunoglobulin class switch recombination. J Exp Med 2009; 206: 1073–1087.

Ma S, Pathak S, Mandal M, Trinh L, Clark MR, Lu R . Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol Cell Biol 2010; 30: 4149–4158.

Eisenbeis CF, Singh H, Storb U . Pip a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 1995; 9: 1377–1387.

Cretney E, Xin A, Shi W, Minnich M, Masson F, Miasari M et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol 2011; 12: 304–311.

Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772–777.

Yasuda K, Richez C, Maciaszek JW, Agrawal N, Akira S, Marshak-Rothstein A et al. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 2007; 178: 6876–6885.

Kasturi SP, Skountzou I, Albrecht RA, Koutsonanos D, Hua T, Nakaya HI et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011; 470: 543–547.

Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K . Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci USA 2010; 107: 10154–10159.

Gerth AJ, Lin L, Peng SL . T-bet regulates T-independent IgG2a class switching. Intern Immunol 2003; 15: 937–944.

Liu N, Ohnishi N, Ni L, Akira S, Bacon KB . CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 2003; 4: 687–693.

Kim J, Sif S, Jones B, Jackson A, Koipally J, Heller E et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 1999; 10: 345–355.

Snapper CM, Paul WE . Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236: 944–947.

Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H . Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 2006; 25: 225–236.

Negishi H, Ohba Y, Yanai H, Takaoka A, Honma K, Yui K et al. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc Natl Acad Sci USA 2005; 102: 15989–15994.

Wan Y, Xiao H, Affolter J, Kim TW, Bulek K, Chaudhuri S et al. Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J Biol Chem 2009; 284: 10367–10375.

Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ et al. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 2010; 120: 3651–3662.

Stone RC, Feng D, Deng J, Singh S, Yang L, Fitzgerald-Bocarsly P et al. IRF5 activation in monocytes of SLE patients is triggered by circulating autoantigens independent of type I IFN. Arthritis Rheum 2012; 64: 788–798.

Virgin HW, Todd JA . Metagenomics and personalized medicine. Cell 2011; 147: 44–56.

Schur PH, Monroe M, Rothfield N . The gammaG subclass of antinuclear and antinucleic acid antibodies. Arthritis Rheum 1972; 15: 174–182.

Casali P . Polyclonal B cell activation and antigen-driven antibody response as mechanisms of autoantibody production in SLE. Autoimmunity 1990; 5: 147–150.

Fu Q, Zhao J, Qian X, Wong JL, Kaufman KM, Yu CY et al. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum 2011; 63: 749–754.